KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Teladoc Health (TDOC) Invested Capital (2016 - 2025)

Teladoc Health's Invested Capital history spans 13 years, with the latest figure at $1.4 billion for Q4 2025.

  • For Q4 2025, Invested Capital fell 32.13% year-over-year to $1.4 billion; the TTM value through Dec 2025 reached $1.4 billion, down 32.13%, while the annual FY2025 figure was $1.4 billion, 32.13% down from the prior year.
  • Invested Capital for Q4 2025 was $1.4 billion at Teladoc Health, roughly flat from $1.4 billion in the prior quarter.
  • Across five years, Invested Capital topped out at $16.0 billion in Q4 2021 and bottomed at $1.4 billion in Q4 2025.
  • The 5-year median for Invested Capital is $2.3 billion (2023), against an average of $5.6 billion.
  • The largest annual shift saw Invested Capital surged 1482.67% in 2021 before it tumbled 85.62% in 2022.
  • A 5-year view of Invested Capital shows it stood at $16.0 billion in 2021, then crashed by 85.62% to $2.3 billion in 2022, then rose by 0.79% to $2.3 billion in 2023, then dropped by 12.22% to $2.0 billion in 2024, then tumbled by 32.13% to $1.4 billion in 2025.
  • Per Business Quant, the three most recent readings for TDOC's Invested Capital are $1.4 billion (Q4 2025), $1.4 billion (Q3 2025), and $1.4 billion (Q2 2025).